Cunningham S A, Waxham M N, Arrate P M, Brock T A
Department of Pharmacology, Texas Biotechnology Corporation, Houston 77030, USA.
J Biol Chem. 1995 Sep 1;270(35):20254-7. doi: 10.1074/jbc.270.35.20254.
We have examined the interactions of the p85 regulatory subunit of phosphatidylinositol 3-kinase with the endothelium-specific Flt-1 receptor tyrosine kinase using the yeast two-hybrid system. We find that both the amino- and carboxyl-terminal SH2 domains of p85 bind to Flt-1. We have performed site-directed mutagenesis on the carboxyl-terminal tail of the Flt-1 receptor in order to identify the site(s) that is responsible for the p85 interactions. A single tyrosine to phenylalanine change at position 1213 inhibits the binding of both p85 SH2 domains. Phosphopeptide mapping of the wild type and mutant protein expressed in insect cells verifies that this amino acid is a target for autophosphorylation. The amino acids following this tyrosine are VNA and thus define a novel binding site for p85.
我们利用酵母双杂交系统研究了磷脂酰肌醇3激酶的p85调节亚基与内皮细胞特异性Flt-1受体酪氨酸激酶之间的相互作用。我们发现p85的氨基末端和羧基末端SH2结构域均与Flt-1结合。我们对Flt-1受体的羧基末端尾巴进行了定点诱变,以确定负责与p85相互作用的位点。第1213位的单个酪氨酸突变为苯丙氨酸会抑制两个p85 SH2结构域的结合。对昆虫细胞中表达的野生型和突变型蛋白进行的磷酸肽图谱分析证实,该氨基酸是自磷酸化的靶点。该酪氨酸之后的氨基酸是VNA,因此定义了一个新的p85结合位点。